 LA JOLLA, Calif.--BUSINESS WIRE--- EQ GVHD--Equillium, Inc. Nasdaq: EQ, a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that it will participate in a fireside chat presentation at the Wells Fargo Healthcare Conference and a corporate presentation at the H.C. Wainwright Annual Global Investment Conference. Management will provide a high-level overview of the company, clini 